The frequencies of VTE did not differ significantly based on INR range or receipt of VTE prophylaxis. Of the 190 patients in the study, 17 (9%) received pharmacologic VTE prophylaxis and 31 (16% ...

In orthopedic trials comparing fondaparinux with enoxaparin for VTE prophylaxis, the mean ± S.D. BMI values of patients treated with fondaparinux and enoxaparin were 27.4 ± 5.6 kg/m 2 and 27.3 ...

Data in the medical literature clearly demonstrate the benefit of prophylaxis for venous thromboembolism (VTE), and current guidelines recommend VTE prophylaxis for most hospitalized patients. 1 ...

Researchers sought to determine risk of venous thromboembolism, based on SAVED and IMPEDE VTE scores, in patients with newly diagnosed multiple myeloma.

Venous thromboembolism (VTE) remains a significant cause of morbidity and mortality among hospitalised medical patients. Ongoing efforts to refine risk assessment and optimise prophylactic ...

SAN FRANCISCO — Receiving ganciclovir prophylaxis did not have a benefit on respiratory support-free days vs. placebo in adults with sepsis-associated respiratory failure and cytomegalovirus ...

The twice-yearly injectable drug’s potential could be compromised by the Trump administration’s dramatic cuts to HIV-prevention infrastructure in the U.S.

Background Venous thromboembolism (VTE) affects >1.2 million Americans annually. Although the clinical outcomes and economic burdens of VTE have been well described, the impact of VTE on patients' ...

Objective To examine patients' understanding of hospital-associated thrombosis, and their experiences of thromboprophylaxis. Design Qualitative study using semi-structured interviews with 31 patients ...

Introduction Hospital-acquired thrombosis accounts for a large proportion of all venous thromboembolism (VTE), with significant morbidity and mortality. This subset of VTE can be reduced through ...

Post-transplant cyclophosphamide (PTCy) plus cyclosporine is more effective than standard graft-vs-host disease (GVHD) prophylaxis in patients undergoing matched sibling peripheral blood stem cell ...

Citation Kolkailah AA, Abdelghaffar B, Elshafeey F, Magdy R, Kamel M, Abuelnaga Y, Nabhan AF, Piazza G. Standard- versus extended-duration anticoagulation for primary venous thromboembolism ...